期刊文献+

PTEN基因在喉鳞癌中的表达及意义 被引量:3

Expression of PTEN gene in human laryngeal carcinoma and its clinical significance
暂未订购
导出
摘要 目的:探讨蛋白酪氨酸磷酸酶基因(PTEN)在喉鳞癌中的表达及其临床意义。方法:应用半定量RT-PCR方法检测喉癌组织中PTENmRNA的表达。结果:淋巴结转移组喉癌较正常喉组织PTENmRNA表达下降有统计学意义(P<0.05)。病理低分化与高分化相比,PTENmRNA表达差异有统计学意义(P<0.05)。结论:PTEN基因表达下降在喉鳞癌演进中起重要作用。 Objective: To detect the mRNA expression of PTEN gene in laryngeal carcinoma, and to explore its clinical significance. Methods: The mRNA expression of PTEN in 40 tumor samples and 9 normal laryngeal samples were examined with RT-PCR. Results: The mRNA expression of PTEN in the normal laryngeal tissue was higher than that in the laryngeal cancer with lymph node metastasis (P<0.05). The difference between high and low differentiation of laryngeal carcinoma was statistically significant (P<0.05). Conclusion: The decreasing of mRNA expression PTEN may be related with the lymph node metastasis and low differentiation of laryngeal squamous cell carcinoma, which suggested that the decreasing of PTEN gene expression may take important effects in the progression of laryngeal carcinoma.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2005年第3期238-239,共2页 Journal of China Medical University
基金 沈阳市社会发展基金资助项目(041101)
关键词 喉肿瘤 PTEN基因 基因表达 laryngeal neoplasm PTEN gene gene expression
  • 相关文献

参考文献2

二级参考文献56

  • 1[1]Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH,Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R,Swedlund B, Teng DH, Tavtigian SV. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15:356-362
  • 2[2]Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J,Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC,Ittmarn M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. PTEN,a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275:1943-1947
  • 3[3]Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997; 57:2124-2129
  • 4[4]Cantley LC, Neel BG.New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 1999; 96: 4240-4245
  • 5[5]Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A 1998; 95:15587-15591
  • 6[6]Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,trisphosphate and Akt/protein kinase B signaling pathway.Proc Natl Acad Sci U S A 1999; 96:6199-6204
  • 7[7]Maehama T, Taylor GS, Dixon JE. PTEN and myotubularin: novel phosphoinositide phosphatases.Annu Rev Biochem 2001; 70: 247-279
  • 8[8]Besson A, Robbins SM, Yong VW. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. Eur J Biochem 1999; 263: 605-611
  • 9[9]Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet 2002; 70:829-844
  • 10[10]Tanno S, Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH, Testa JR. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res 2001; 61:589-593

共引文献127

同被引文献33

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部